Annexin A2 regulates the levels of plasmin, S100A10 and fascin in L5178Y cells

Cancer Investigation

Volumn 26, Issue 8, 2008, Pages 809-815

  Hou, Yingchun ^a   Yang, Lijuan ^b   Mou, Maosen ^a   Hou, Yang ^c   Zhang, Airan ^a   Pan, Ning ^a   Qiang, Rongbin ^a   Wei, Lili ^a   Zhang, Nannan ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Metastasis; Annexin A2; Cancer cells; Gene expression; Gene knockout; Invasion

Indexed keywords

CALCIUM BINDING PROTEIN; FASCIN; LIPOCORTIN 2; PLASMIN; PLASMINOGEN; PROTEIN S100A10; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; GENE CONTROL; GENETIC TRANSCRIPTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; ANNEXIN A2; CARRIER PROTEINS; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION, LEUKEMIC; GENE TARGETING; LEUKEMIA L5178; MICE; MICROFILAMENT PROTEINS; NEOPLASM PROTEINS; PLASMIN; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; S100 PROTEINS;

EID: 53949091796     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900801898664     Document Type: Article

References (34)

1. Moss, S.E.; Morgan, R.O. The annexins. Genome Biol 2004, 5, 219.
2. Gerke, V.; Moss, S.E. Annexins: From structure to function. Physiol Rev 2001, 82, 331-371.
3. Chetcuti, A.; Margan, S.H.; Russell, P.; Mann, S.; Millar,D.S.; Clark, S.J.; et al. Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res 2001, 61, 6331-6334.
4. Cesarman-Maus, G.; Hajjar, K.A. Molecular mechanisms of fibrinolysis. Br J Haematol 2005, 129, 307-321.
5. Tuszynski, G.P.; Sharma, M.R.; Rothman, V.L.; Sharma, M.C. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells. Microvascular Res 2002, 64, 448-462.
6. Kwon, M.; Caplan, J.F.; Filipenko, N.R.; Choi, K.S.; Fitzpatrick, S.L.; Zhang, L.; et al. Identification of annexin II heterotetramer as a plasmin reductase. J Biol Chem 2002, 277, 10903-10911.
7. Waisman, D.M. Annexin A2 may not play a role as a plasminogen receptor. Br J Haematol 2005, 131, 553-554.
8. Kwon, M.; MacLeod, T.J.; Zhang, Y.; Waisman, D.M. S100A10, annexin A2, and annexin A2 heterotetramer as candidate plasminogen receptors. Front Biosci 2005, 10, 300-325.
9. Semov, A.; Moreno, M.J.; Onichtchenko, A.; Abulrob, A.; Ball, M.; Ekiel, I.; et al. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 2005, 280, 20833-20841.
10. Garrett, S.C.; Varney, K.M.; Weber, D.J.; Bresnick, A.R. S100A4, a mediator of metastasis. J Biol Chem 2006, 281, 677-680.
11. Sharma, M.R.; Koltowski, L.; Ownbey, R.T.; Tuszynski, G.P.; Sharma, M.C. Angiogenesis-associated protein annexin II in breast cancer: Selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 2006, 81, 146-156.
12. Sharma, M.R.; Rothman, V.; Tuszynski, G.P.; Sharma; M.C. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: Possible biochemical mechanism of angiostatin's action. Exp Mol Pathol 2006, 81, 136-145.
13. Hashimoto, Y.; Shimada, Y.; Kawamura, J.; Yamasaki, S.; Imamura, M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncol 2004, 67, 262-270.
14. Pelosi, G.; Pastorino, U.; Pasini, F.; Maissoneuve, P.; Fraggetta, F.; Iannucci, A. et al. Independent prognostic value of fascin immunoreactivity in stage I non-small cell lung cancer. Br J Cancer 2003, 88, 537-547.
15. Hashimoto, Y.; Ito, T.; Inoue, H.; Okumura, T.; Tanaka, E.; Tsunoda, S. et al. Prognostic significance of fascin overexpression in human esophageal squamouscell carcinoma. Clin Cancer Res 2005, 11, 2597-2605.
16. Hou, Y.; Hirata, A.; Hirata, F. Construction of mouse annexin II gene knockout recombinant and generation of mouse annexin II-/- cell line. Chin J Cell Biol 2006, 28, 721-725.
17. T) method. Methods 2001, 25, 402-408.
18. Markoff, A.; Gerke, V. Expression and functions of annexins in the kidney. Am J Physiol Renal Physiol 2005, 289, F949-956.
19. Liu, J.W.; Shen, J.J.; Tanzillo-Swarts, A.; Bhatia, B.; Maldonado, C.M.; Person, M.D. et al. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 2003, 22, 1475-1485.
20. Domoto, T.; Miyama, Y.; Suzuki, H.; Teratani, T.; Arai, K.; Sugiyama, T. et al. Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci 2007, 98, 77-82.
21. Zhang, L.; Fogg, D.K.; Waisman, D.M. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem 2004, 279, 2053-2062.
22. Díaz, V.M.; Hurtado, M.; Thomson, T.M.; Reventós, J.; Paciucci, R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 2004, 53, 993-1000.
23. Brownstein, C.; Falcone, D.J.; Jacovina, A.; Hajjar, K.A. A mediator of cell surface-specific plasmin generation. Ann NY Acad Sci 2001, 947, 143-156.
24. Kim, J.; Hajjar; K.A. Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci 2002, 7, d341-348.
25. Hajjar, K.A.; Krishnan, S. Annexin II: a mediator of the plasmin/plasminogen activator system. Trends Cardiovasc Med 1999, 9, 128-138.
26. Fitzpatrick, S.L.; Kassam, G.; Choi, K.S.; Kang, H.M.; Fogg, D.K.; Waisman, D.M. Regulation of plasmin activity by annexin II tetramer. Biochemistry 2000, 39, 1021-1028.
27. Kang, H.M.; Choi, K.S.; Kassam, G.; Fitzpatrick, S.L.; Kwon, M.; Waisman, D.M. Role of annexin II tetramer in plasminogen activation. Trends Cardiovasc Med 1999, 9, 92-102.
28. Kassam, G.; Choi, K.S.; Ghuman, J.; Kang, H.M.; Fitzpatrick, S.L.; Zackson, T.; et al. The role of annexin II tetramer in the activation of plasminogen. J Biol Chem 1998, 273, 4790-4799.
29. Vignjevic, D.; Schoumacher, M.; Gavert, N.; Janssen, K.P.; Jih, G.; Láe, M.; et al. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 2007, 67, 6844-6853.
30. Adams, J.C. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004, 16, 590-596.
31. Chen, S.F.; Yang, S.F.; Li, J.W.; Nieh, P.C.; Lin, S.Y.; Fu, E.; et al. Expression of fascin in oral and oropharyngeal squamous cell carcinomas has prognostic significance - a tissue microarray study of 129 cases. Histopathol 2007, 51, 173-183.
32. Lee, T.K.; Poon, R.T.; Man, K.; Guan, X.Y.; Ma, S.; Liu, X.B.; et al. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett 2007, Epub.
33. Tsai, W.C.; Chao, Y.C.; Sheu, L.F.; Chang, J.L.; Nieh, S.; Jin, J.S. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers 2007, 23, 153-160.
34. Okada, K.; Shimura, T.; Asakawa, K.; Hashimoto, S.; Mochida, Y.; Suehiro, T.; et al. Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer, Hepatogastroenterology 2007, 54, 17-21.